Drugs Made In America Acquisition DMAAR
NASDAQ DMAAR
$0.13 +0.01 (+8.33%)
At close: Sep 17, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition Corp. (DMAAR) Debt Ratio (2024 - 2026)

Drugs Made In America Acquisition's (DMAAR) quarterly Debt Ratio came in at 0.0 in Q2 2026, up 355.41% quarter-over-quarter from 0.0 in Q1 2025.

Analysis

Drugs Made In America Acquisition Corp. (DMAAR) Debt Ratio (2024 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMAAR) has reported Debt Ratio for 3 consecutive years, with 0.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2026 stood at 0.0 (changed N/A YoY), and the FY2024 full-year result was 2.4, changed N/A from the prior year.
  • Debt Ratio rose to 0.0 in Q2 2026 per DMAAR's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 2.4 in Q4 2024 and bottomed at 0.0 in Q1 2025.
  • Historically, Debt Ratio has averaged 0.8 across 3 years, with a median of 0.0 in 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2025 0.00
Dec 31, 2024 2.40